Home Finance specialist Mintz Venture Watch—Volume 2: A Report on 3rd and 4th Quarter 2021 Deal Trends – Corporate/Commercial

Mintz Venture Watch—Volume 2: A Report on 3rd and 4th Quarter 2021 Deal Trends – Corporate/Commercial


United States: Mintz Venture Watch – Volume 2: A Third and Fourth Quarter 2021 Deal Trend Report

To print this article, all you need to do is be registered or log in to Mondaq.com.


The second half of 2021 continued to show strong venture capital investment activity across a wide range of sectors. Technology and life sciences deals were the dominant force in the more than 65 deals the Mintz team processed in the second half of the year. Below we highlight some of our interesting deals.


Mintz advised T-REX Group, a fintech company that developed a SaaS platform to more accurately and efficiently price securities in complex asset classes, including alternative energy, during the initial closing of a $40 million Series C financing. T-REX was founded to fill two distinct gaps in the market: the absence of modern technology to power the financing of complex assets and the need for tools to accelerate investments in the energy transition. This funding will facilitate transformational change in sustainable infrastructure investing and capital markets more broadly.

Life sciences

Mintz advised Cardurion Pharmaceuticals, Inc., a clinical-stage biotechnology company, in a recently closed private equity investment of up to $300 million from Bain Capital Life Sciences and Bain Capital Private Equity. Bain Capital joins existing investors Takeda Pharmaceuticals and Polaris Partners to support Cardurion’s evolution into a leading cardiovascular biotechnology company. This latest investment will support the thoughtful advancement of Cardurion’s pipeline, allowing the company to scale its team and build a cutting-edge platform.


Gluware, a company rich in IP assets, raised $35 million from Bain Capital Credit using a new financing alternative called IP-backed debt. Mintz advised Gluware, Inc. in this innovative fundraising transaction which closed in October 2021. These intellectual property-backed loans provide significant growth capital to companies that are normally excluded from debt financing markets.

The content of this article is intended to provide a general guide on the subject. Specialist advice should be sought regarding your particular situation.

POPULAR ARTICLES ON: US Corporate/Commercial Law

Goodwill and Mister Donut – A business in operation?

Ruchelman SARL

Selling a business to a buyer often involves an element of goodwill, a term that can have different meanings in different contexts, depending on whether or not the term relates to…

The limits of compensation

Edlin Gallagher Oil + Blum

Indemnity is a hard-fought aspect of commercial contracts. The objective of indemnification is to entrust the various risks to the party best able to respond to them.

M&A in 2021 and trends for 2022

Morrison & Foerster LLP

2021 mergers and acquisitions broke US and global records. The year saw the arrival of a new US administration, the release of COVID-19 vaccines, as well as lingering questions about the impact of the pandemic…